 Sharon Poisson
Concepts (180)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 33 | 2025 | 1133 | 4.390 |
Why?
| | Ischemic Attack, Transient | 9 | 2022 | 66 | 2.230 |
Why?
| | Brain Ischemia | 11 | 2023 | 342 | 1.830 |
Why?
| | Foramen Ovale, Patent | 2 | 2023 | 10 | 0.980 |
Why?
| | Atherosclerosis | 2 | 2022 | 414 | 0.680 |
Why?
| | Motor Disorders | 1 | 2019 | 15 | 0.590 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2019 | 154 | 0.540 |
Why?
| | Neurology | 2 | 2024 | 111 | 0.460 |
Why?
| | Intracranial Hemorrhages | 1 | 2014 | 87 | 0.430 |
Why?
| | Kynurenine | 2 | 2025 | 114 | 0.420 |
Why?
| | Status Epilepticus | 1 | 2014 | 50 | 0.420 |
Why?
| | Cerebral Hemorrhage | 1 | 2014 | 111 | 0.420 |
Why?
| | Endarterectomy, Carotid | 2 | 2011 | 54 | 0.410 |
Why?
| | Carotid Stenosis | 2 | 2011 | 96 | 0.390 |
Why?
| | Sex Characteristics | 5 | 2024 | 770 | 0.380 |
Why?
| | Cross Infection | 2 | 2016 | 250 | 0.370 |
Why?
| | Aged | 20 | 2025 | 23995 | 0.300 |
Why?
| | Sex Factors | 6 | 2024 | 2071 | 0.300 |
Why?
| | Male | 30 | 2025 | 67984 | 0.300 |
Why?
| | Humans | 44 | 2025 | 138102 | 0.300 |
Why?
| | Female | 31 | 2025 | 73648 | 0.300 |
Why?
| | Catheter-Related Infections | 1 | 2010 | 90 | 0.300 |
Why?
| | Disability Evaluation | 2 | 2021 | 297 | 0.290 |
Why?
| | Risk Assessment | 6 | 2025 | 3471 | 0.280 |
Why?
| | Patient Care | 1 | 2009 | 112 | 0.280 |
Why?
| | Cerebral Arterial Diseases | 2 | 2019 | 49 | 0.270 |
Why?
| | Urinary Tract Infections | 1 | 2010 | 191 | 0.270 |
Why?
| | Clinical Clerkship | 1 | 2009 | 104 | 0.270 |
Why?
| | Patients | 1 | 2009 | 178 | 0.270 |
Why?
| | Endovascular Procedures | 2 | 2025 | 340 | 0.270 |
Why?
| | Cohort Studies | 7 | 2025 | 5731 | 0.270 |
Why?
| | Young Adult | 11 | 2024 | 13329 | 0.260 |
Why?
| | Risk Factors | 11 | 2025 | 10433 | 0.260 |
Why?
| | Tryptophan | 2 | 2025 | 183 | 0.250 |
Why?
| | Retrospective Studies | 17 | 2025 | 15750 | 0.250 |
Why?
| | Aged, 80 and over | 13 | 2025 | 7638 | 0.250 |
Why?
| | Educational Measurement | 1 | 2009 | 290 | 0.250 |
Why?
| | United States | 12 | 2022 | 15028 | 0.240 |
Why?
| | Emergency Service, Hospital | 5 | 2022 | 2092 | 0.240 |
Why?
| | Thrombectomy | 1 | 2025 | 73 | 0.220 |
Why?
| | Adult | 16 | 2024 | 38063 | 0.220 |
Why?
| | Middle Aged | 20 | 2025 | 33509 | 0.210 |
Why?
| | Pneumonia | 2 | 2021 | 638 | 0.200 |
Why?
| | Theft | 1 | 2022 | 2 | 0.200 |
Why?
| | Migraine Disorders | 1 | 2024 | 104 | 0.190 |
Why?
| | Emergency Medical Services | 3 | 2022 | 560 | 0.190 |
Why?
| | Urban Population | 1 | 2025 | 481 | 0.190 |
Why?
| | Metabolomics | 2 | 2024 | 686 | 0.190 |
Why?
| | Psychomotor Performance | 1 | 2025 | 312 | 0.180 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2022 | 130 | 0.180 |
Why?
| | Dizziness | 2 | 2012 | 82 | 0.180 |
Why?
| | Clinical Competence | 1 | 2009 | 1123 | 0.170 |
Why?
| | Metabolome | 1 | 2024 | 351 | 0.170 |
Why?
| | Rural Population | 1 | 2025 | 585 | 0.170 |
Why?
| | Prevalence | 4 | 2022 | 2762 | 0.170 |
Why?
| | Neuroimaging | 2 | 2020 | 261 | 0.170 |
Why?
| | Cerebrovascular Disorders | 1 | 2021 | 96 | 0.170 |
Why?
| | Clinical Trials as Topic | 2 | 2019 | 1032 | 0.170 |
Why?
| | Education, Medical | 1 | 2024 | 273 | 0.170 |
Why?
| | Carotid Artery, Internal, Dissection | 1 | 2020 | 13 | 0.170 |
Why?
| | Case-Control Studies | 3 | 2024 | 3569 | 0.170 |
Why?
| | Vertebral Artery Dissection | 1 | 2020 | 25 | 0.170 |
Why?
| | Hypertension | 2 | 2024 | 1310 | 0.160 |
Why?
| | Age Distribution | 1 | 2020 | 400 | 0.160 |
Why?
| | Sex Distribution | 1 | 2020 | 383 | 0.160 |
Why?
| | Incidence | 3 | 2022 | 2827 | 0.150 |
Why?
| | Aspirin | 2 | 2013 | 391 | 0.150 |
Why?
| | Healthcare Disparities | 1 | 2025 | 662 | 0.150 |
Why?
| | Neurologic Examination | 1 | 2019 | 125 | 0.150 |
Why?
| | Platelet Aggregation Inhibitors | 2 | 2013 | 468 | 0.140 |
Why?
| | Aftercare | 1 | 2020 | 208 | 0.140 |
Why?
| | Follow-Up Studies | 6 | 2020 | 5144 | 0.140 |
Why?
| | Internationality | 1 | 2019 | 159 | 0.140 |
Why?
| | Health Services Accessibility | 1 | 2025 | 996 | 0.140 |
Why?
| | Intracranial Arterial Diseases | 1 | 2017 | 8 | 0.140 |
Why?
| | Nutrition Surveys | 1 | 2019 | 270 | 0.130 |
Why?
| | Guideline Adherence | 1 | 2022 | 557 | 0.130 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2017 | 21 | 0.130 |
Why?
| | Cerebral Arteries | 1 | 2017 | 58 | 0.130 |
Why?
| | Cognition | 1 | 2025 | 1173 | 0.130 |
Why?
| | Secondary Prevention | 1 | 2018 | 234 | 0.130 |
Why?
| | Adolescent | 7 | 2022 | 21637 | 0.120 |
Why?
| | Machine Learning | 1 | 2021 | 516 | 0.120 |
Why?
| | Practice Guidelines as Topic | 2 | 2022 | 1557 | 0.120 |
Why?
| | Heart Septal Defects, Atrial | 1 | 2016 | 53 | 0.120 |
Why?
| | Ambulatory Care | 1 | 2020 | 571 | 0.120 |
Why?
| | Soft Tissue Infections | 1 | 2015 | 38 | 0.120 |
Why?
| | Magnetic Resonance Angiography | 1 | 2017 | 240 | 0.120 |
Why?
| | Cost-Benefit Analysis | 1 | 2018 | 585 | 0.120 |
Why?
| | Pregnancy Complications | 1 | 2020 | 530 | 0.120 |
Why?
| | Patient Readmission | 1 | 2020 | 702 | 0.110 |
Why?
| | Age Factors | 1 | 2022 | 3285 | 0.110 |
Why?
| | Internal Medicine | 1 | 2015 | 271 | 0.100 |
Why?
| | Information Seeking Behavior | 1 | 2012 | 37 | 0.090 |
Why?
| | Prognosis | 3 | 2021 | 3982 | 0.090 |
Why?
| | Central Nervous System Diseases | 1 | 2012 | 71 | 0.090 |
Why?
| | Electroencephalography | 1 | 2014 | 434 | 0.090 |
Why?
| | Education, Medical, Graduate | 1 | 2015 | 485 | 0.090 |
Why?
| | Anticoagulants | 2 | 2017 | 659 | 0.090 |
Why?
| | Child | 5 | 2022 | 21990 | 0.090 |
Why?
| | Infant, Newborn | 1 | 2022 | 6140 | 0.080 |
Why?
| | Patient Discharge | 3 | 2022 | 907 | 0.080 |
Why?
| | Critical Care | 1 | 2015 | 615 | 0.080 |
Why?
| | Odds Ratio | 3 | 2021 | 1077 | 0.080 |
Why?
| | Diagnosis, Differential | 1 | 2014 | 1490 | 0.080 |
Why?
| | Sepsis | 1 | 2016 | 602 | 0.080 |
Why?
| | Inflammation | 1 | 2021 | 2847 | 0.080 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 2029 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2011 | 229 | 0.080 |
Why?
| | Disease Progression | 1 | 2017 | 2730 | 0.080 |
Why?
| | Dyslipidemias | 1 | 2011 | 178 | 0.080 |
Why?
| | Catheters, Indwelling | 1 | 2010 | 89 | 0.080 |
Why?
| | Critical Illness | 1 | 2015 | 806 | 0.080 |
Why?
| | Cross-Sectional Studies | 5 | 2022 | 5556 | 0.080 |
Why?
| | Curriculum | 1 | 2015 | 1003 | 0.070 |
Why?
| | Fibrinolytic Agents | 1 | 2011 | 274 | 0.070 |
Why?
| | Diagnostic Imaging | 1 | 2011 | 329 | 0.070 |
Why?
| | Cerebrovascular Circulation | 1 | 2010 | 252 | 0.070 |
Why?
| | Infant | 1 | 2022 | 9566 | 0.070 |
Why?
| | Inpatients | 2 | 2024 | 498 | 0.070 |
Why?
| | Electrocardiography | 1 | 2011 | 611 | 0.070 |
Why?
| | Child, Preschool | 1 | 2022 | 11142 | 0.070 |
Why?
| | Antihypertensive Agents | 1 | 2011 | 499 | 0.070 |
Why?
| | Atrial Fibrillation | 1 | 2011 | 378 | 0.070 |
Why?
| | Nervous System Diseases | 1 | 2009 | 273 | 0.060 |
Why?
| | Colorado | 2 | 2025 | 4553 | 0.060 |
Why?
| | Hospital Mortality | 2 | 2021 | 912 | 0.050 |
Why?
| | Infarction | 1 | 2023 | 11 | 0.050 |
Why?
| | Individuality | 1 | 2025 | 158 | 0.050 |
Why?
| | Databases, Factual | 2 | 2021 | 1381 | 0.050 |
Why?
| | Diabetes Mellitus | 1 | 2011 | 1059 | 0.050 |
Why?
| | Middle Cerebral Artery | 1 | 2022 | 53 | 0.050 |
Why?
| | Infarction, Middle Cerebral Artery | 1 | 2022 | 42 | 0.050 |
Why?
| | Emergency Medical Dispatch | 1 | 2022 | 6 | 0.050 |
Why?
| | Up-Regulation | 1 | 2025 | 844 | 0.050 |
Why?
| | Information Systems | 1 | 2022 | 60 | 0.050 |
Why?
| | Survivors | 1 | 2025 | 503 | 0.040 |
Why?
| | Multivariate Analysis | 2 | 2016 | 1495 | 0.040 |
Why?
| | Time Factors | 2 | 2025 | 6845 | 0.040 |
Why?
| | Neuropsychological Tests | 1 | 2025 | 1047 | 0.040 |
Why?
| | Executive Function | 1 | 2025 | 450 | 0.040 |
Why?
| | Reproducibility of Results | 2 | 2019 | 3301 | 0.040 |
Why?
| | Cognitive Dysfunction | 1 | 2025 | 390 | 0.040 |
Why?
| | Comorbidity | 2 | 2016 | 1638 | 0.040 |
Why?
| | Brain | 1 | 2011 | 2725 | 0.040 |
Why?
| | Communication | 1 | 2024 | 924 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2021 | 971 | 0.030 |
Why?
| | Dura Mater | 1 | 2017 | 34 | 0.030 |
Why?
| | Medicare | 1 | 2022 | 786 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 329 | 0.030 |
Why?
| | California | 1 | 2016 | 439 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1265 | 0.030 |
Why?
| | Cardiac Catheterization | 1 | 2018 | 514 | 0.030 |
Why?
| | Chronic Disease | 1 | 2021 | 1791 | 0.030 |
Why?
| | Combined Modality Therapy | 1 | 2017 | 1234 | 0.030 |
Why?
| | Biomarkers | 1 | 2025 | 4111 | 0.030 |
Why?
| | Ticlopidine | 1 | 2013 | 52 | 0.030 |
Why?
| | Online Systems | 1 | 2012 | 21 | 0.020 |
Why?
| | Global Health | 1 | 2016 | 384 | 0.020 |
Why?
| | Diagnostic Self Evaluation | 1 | 2012 | 23 | 0.020 |
Why?
| | Uncompensated Care | 1 | 2012 | 18 | 0.020 |
Why?
| | Medical History Taking | 1 | 2012 | 117 | 0.020 |
Why?
| | Ambulances | 1 | 2012 | 51 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2012 | 334 | 0.020 |
Why?
| | Symptom Assessment | 1 | 2012 | 129 | 0.020 |
Why?
| | Geography | 1 | 2012 | 204 | 0.020 |
Why?
| | Logistic Models | 1 | 2016 | 2081 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2838 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2018 | 10832 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2013 | 1034 | 0.020 |
Why?
| | Magnetic Resonance Imaging | 1 | 2022 | 3608 | 0.020 |
Why?
| | Health Care Surveys | 1 | 2012 | 565 | 0.020 |
Why?
| | Health Surveys | 1 | 2012 | 523 | 0.020 |
Why?
| | Emergency Medicine | 1 | 2012 | 235 | 0.020 |
Why?
| | Blood Platelets | 1 | 2013 | 421 | 0.020 |
Why?
| | Double-Blind Method | 1 | 2013 | 1922 | 0.020 |
Why?
| | Self Report | 1 | 2012 | 838 | 0.020 |
Why?
| | Pregnancy | 1 | 2020 | 6789 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2012 | 1312 | 0.020 |
Why?
| | Research Design | 1 | 2013 | 1122 | 0.020 |
Why?
|
|
Poisson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|